Corticosteroids as adjuvant therapy for ocular toxoplasmosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Corticosteroids as Adjuvant Therapy for Ocular Toxoplasmosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Corticosteroids_as_adjuvant_therapy_for_ocular_toxoplasmosis.
Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Corticosteroids_as_adjuvant_therapy_for_ocular_toxoplasmosis. Accessed February 10, 2025.
Corticosteroids as adjuvant therapy for ocular toxoplasmosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Corticosteroids_as_adjuvant_therapy_for_ocular_toxoplasmosis
Corticosteroids as Adjuvant Therapy for Ocular Toxoplasmosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Corticosteroids_as_adjuvant_therapy_for_ocular_toxoplasmosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Corticosteroids as adjuvant therapy for ocular toxoplasmosis
ID - 435892
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Corticosteroids_as_adjuvant_therapy_for_ocular_toxoplasmosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -